東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/21 | 2,765 | 2,818 | 2,765 | 2,811 | +8 | +0.3% | 51,600 |
| 2024/08/20 | 2,773 | 2,815 | 2,767 | 2,803 | +23 | +0.8% | 74,400 |
| 2024/08/19 | 2,810 | 2,817 | 2,765 | 2,780 | -47 | -1.7% | 57,100 |
| 2024/08/16 | 2,828 | 2,838 | 2,805 | 2,827 | +49 | +1.8% | 81,500 |
| 2024/08/15 | 2,810 | 2,822 | 2,740 | 2,778 | +4 | +0.1% | 103,300 |
| 2024/08/14 | 2,728 | 2,840 | 2,728 | 2,774 | +46 | +1.7% | 155,300 |
| 2024/08/13 | 2,670 | 2,740 | 2,637 | 2,728 | +70 | +2.6% | 210,900 |
| 2024/08/09 | 2,706 | 2,847 | 2,609 | 2,658 | +121 | +4.8% | 326,400 |
| 2024/08/08 | 2,530 | 2,594 | 2,519 | 2,537 | -40 | -1.6% | 170,400 |
| 2024/08/07 | 2,493 | 2,659 | 2,493 | 2,577 | -13 | -0.5% | 164,500 |
| 2024/08/06 | 2,596 | 2,701 | 2,565 | 2,590 | +33 | +1.3% | 124,800 |
| 2024/08/05 | 2,621 | 2,680 | 2,488 | 2,557 | -214 | -7.7% | 203,500 |
| 2024/08/02 | 2,780 | 2,844 | 2,721 | 2,771 | -109 | -3.8% | 152,600 |
| 2024/08/01 | 3,040 | 3,040 | 2,870 | 2,880 | -185 | -6% | 103,400 |
| 2024/07/31 | 2,992 | 3,070 | 2,991 | 3,065 | +73 | +2.4% | 78,900 |
| 2024/07/30 | 3,035 | 3,040 | 2,962 | 2,992 | -38 | -1.3% | 76,800 |
| 2024/07/29 | 2,995 | 3,065 | 2,981 | 3,030 | +35 | +1.2% | 64,400 |
| 2024/07/26 | 3,035 | 3,035 | 2,987 | 2,995 | -35 | -1.2% | 59,000 |
| 2024/07/25 | 3,030 | 3,045 | 2,988 | 3,030 | -15 | -0.5% | 107,600 |
| 2024/07/24 | 3,050 | 3,065 | 3,025 | 3,045 | -10 | -0.3% | 53,900 |
| 2024/07/23 | 3,045 | 3,070 | 3,035 | 3,055 | +20 | +0.7% | 30,400 |
| 2024/07/22 | 3,065 | 3,070 | 3,020 | 3,035 | -20 | -0.7% | 59,500 |
| 2024/07/19 | 3,060 | 3,065 | 3,000 | 3,055 | -20 | -0.7% | 70,800 |
| 2024/07/18 | 3,045 | 3,090 | 3,015 | 3,075 | +15 | +0.5% | 68,600 |
| 2024/07/17 | 3,060 | 3,090 | 3,045 | 3,060 | +25 | +0.8% | 79,500 |
| 2024/07/16 | 3,080 | 3,100 | 3,015 | 3,035 | -20 | -0.7% | 94,600 |
| 2024/07/12 | 3,080 | 3,100 | 3,020 | 3,055 | -30 | -1% | 126,000 |
| 2024/07/11 | 3,030 | 3,085 | 3,010 | 3,085 | +87 | +2.9% | 96,500 |
| 2024/07/10 | 2,992 | 3,050 | 2,972 | 2,998 | +6 | +0.2% | 88,300 |
| 2024/07/09 | 2,947 | 2,999 | 2,924 | 2,992 | +48 | +1.6% | 96,100 |
| 2024/07/08 | 2,958 | 2,979 | 2,925 | 2,944 | -5 | -0.2% | 75,600 |
| 2024/07/05 | 2,980 | 2,993 | 2,949 | 2,949 | -35 | -1.2% | 75,500 |
| 2024/07/04 | 3,025 | 3,045 | 2,979 | 2,984 | -36 | -1.2% | 70,800 |
| 2024/07/03 | 3,010 | 3,040 | 2,936 | 3,020 | +29 | +1% | 115,600 |
| 2024/07/02 | 3,070 | 3,130 | 2,978 | 2,991 | +36 | +1.2% | 231,500 |
| 2024/07/01 | 2,939 | 2,964 | 2,938 | 2,955 | +16 | +0.5% | 51,400 |
| 2024/06/28 | 2,904 | 2,939 | 2,904 | 2,939 | +8 | +0.3% | 55,600 |
| 2024/06/27 | 2,900 | 2,934 | 2,894 | 2,931 | +28 | +1% | 64,300 |
| 2024/06/26 | 2,919 | 2,947 | 2,893 | 2,903 | -5 | -0.2% | 133,000 |
| 2024/06/25 | 2,899 | 2,921 | 2,887 | 2,908 | +28 | +1% | 59,500 |
| 2024/06/24 | 2,891 | 2,918 | 2,865 | 2,880 | +18 | +0.6% | 85,300 |
| 2024/06/21 | 2,871 | 2,918 | 2,850 | 2,862 | -8 | -0.3% | 144,200 |
| 2024/06/20 | 2,901 | 2,911 | 2,852 | 2,870 | -65 | -2.2% | 119,800 |
| 2024/06/19 | 2,916 | 2,935 | 2,870 | 2,935 | ±0 | ±0% | 84,800 |
| 2024/06/18 | 3,040 | 3,055 | 2,923 | 2,935 | -90 | -3% | 124,600 |
| 2024/06/17 | 3,005 | 3,025 | 2,938 | 3,025 | +15 | +0.5% | 130,600 |
| 2024/06/14 | 2,989 | 3,030 | 2,955 | 3,010 | +52 | +1.8% | 150,500 |
| 2024/06/13 | 2,979 | 2,989 | 2,934 | 2,958 | -21 | -0.7% | 85,800 |
| 2024/06/12 | 2,954 | 2,980 | 2,921 | 2,979 | +15 | +0.5% | 116,700 |
| 2024/06/11 | 2,819 | 2,983 | 2,819 | 2,964 | +145 | +5.1% | 168,100 |
151～
200
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
